See more : Bauhaus International (Holdings) Limited (0483.HK) Income Statement Analysis – Financial Results
Complete financial analysis of Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. (300501.SZ) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd., a leading company in the Packaging & Containers industry within the Consumer Cyclical sector.
- Sonic Healthcare Limited (SKHCF) Income Statement Analysis – Financial Results
- Shanghai Dazhong Public Utilities(Group) Co.,Ltd. (600635.SS) Income Statement Analysis – Financial Results
- Cresco Labs Inc. (CL.CN) Income Statement Analysis – Financial Results
- Guizhou Guihang Automotive Components Co.,Ltd (600523.SS) Income Statement Analysis – Financial Results
- American River Bankshares (AMRB) Income Statement Analysis – Financial Results
Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. (300501.SZ)
About Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd.
Shanghai Haishun New Pharmaceutical Packaging Co.,Ltd. manufactures, sells, and exports primarily pharmaceutical packaging films in China and internationally. It offers cold-forming aluminum foils, PVC/Aclar high barrier thermoformable films, tropical blister foils, lidding foils for PTP blisters, AL/PE suppository laminates, child-resistant packaging, complex laminated flexible films, AL/PE strip packs, and PVC/PVDC transparent films under the HiPack brand name. The company is headquartered in Shanghai, China.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.02B | 1.01B | 856.86M | 713.78M | 621.03M | 507.20M | 375.62M | 301.28M | 293.98M | 289.85M | 277.37M | 210.24M | 149.00M |
| Cost of Revenue | 725.98M | 740.93M | 609.81M | 469.97M | 427.52M | 341.49M | 235.14M | 184.72M | 185.93M | 188.20M | 182.27M | 139.11M | 99.05M |
| Gross Profit | 294.89M | 271.67M | 247.05M | 243.81M | 193.51M | 165.70M | 140.48M | 116.56M | 108.05M | 101.65M | 95.10M | 71.12M | 49.95M |
| Gross Profit Ratio | 28.89% | 26.83% | 28.83% | 34.16% | 31.16% | 32.67% | 37.40% | 38.69% | 36.75% | 35.07% | 34.29% | 33.83% | 33.52% |
| Research & Development | 50.35M | 44.49M | 32.88M | 24.29M | 26.44M | 23.26M | 16.87M | 16.36M | 16.78M | 16.16M | 15.70M | 10.14M | 0.00 |
| General & Administrative | 63.73M | 14.89M | 12.92M | 16.47M | 27.12M | 13.16M | 12.81M | 5.90M | 5.17M | 2.83M | 3.30M | 2.51M | 16.21M |
| Selling & Marketing | 54.73M | 45.61M | 42.56M | 50.96M | 38.64M | 31.78M | 21.90M | 14.43M | 13.04M | 13.53M | 12.86M | 10.21M | 8.28M |
| SG&A | 117.17M | 60.49M | 55.48M | 67.43M | 65.76M | 44.94M | 34.71M | 20.33M | 18.22M | 16.36M | 16.16M | 12.72M | 24.49M |
| Other Expenses | 18.22M | 240.12K | -351.52K | -700.08K | -801.56K | 122.66K | 915.11K | 928.29K | 2.13M | 2.71M | 889.78K | 178.97K | 52.56K |
| Operating Expenses | 185.75M | 149.09M | 136.03M | 127.94M | 126.61M | 92.05M | 66.37M | 47.85M | 44.05M | 40.55M | 38.68M | 29.08M | 24.62M |
| Cost & Expenses | 911.72M | 890.03M | 745.85M | 597.91M | 554.13M | 433.54M | 301.50M | 232.57M | 229.98M | 228.75M | 220.95M | 168.19M | 123.67M |
| Interest Income | 12.10M | 7.37M | 2.50M | 586.61K | 955.60K | 344.24K | 849.73K | 661.67K | 495.32K | 252.69K | 280.37K | 149.66K | -0.10 |
| Interest Expense | 11.48M | 5.32M | 9.21M | 8.85M | 7.16M | 1.96M | 303.75K | 271.33K | 2.96K | 13.40K | 215.01K | 681.55K | 688.22K |
| Depreciation & Amortization | 54.84M | 46.99M | 39.16M | 37.66M | 36.34M | 24.74M | 12.60M | 7.39M | 6.90M | 7.26M | 6.80M | 6.14M | 3.41M |
| EBITDA | 175.29M | 178.21M | 154.06M | 162.19M | 113.34M | 104.31M | 90.17M | 81.88M | 75.88M | 68.36M | 60.91M | 48.95M | 26.70M |
| EBITDA Ratio | 17.17% | 18.02% | 19.50% | 23.01% | 18.67% | 20.79% | 24.12% | 27.55% | 25.87% | 23.67% | 22.72% | 22.90% | 17.92% |
| Operating Income | 109.15M | 122.68M | 117.79M | 119.44M | 73.93M | 76.88M | 75.96M | 72.99M | 66.37M | 61.19M | 53.01M | 41.03M | 23.29M |
| Operating Income Ratio | 10.69% | 12.12% | 13.75% | 16.73% | 11.90% | 15.16% | 20.22% | 24.23% | 22.58% | 21.11% | 19.11% | 19.52% | 15.63% |
| Total Other Income/Expenses | -177.81K | 240.12K | -351.52K | -700.08K | -801.56K | 122.67K | 915.11K | 920.86K | 2.12M | 2.71M | 886.58K | 160.61K | 26.16K |
| Income Before Tax | 108.97M | 122.92M | 117.43M | 118.74M | 73.13M | 77.00M | 76.87M | 73.86M | 68.49M | 63.90M | 53.89M | 41.19M | 23.32M |
| Income Before Tax Ratio | 10.67% | 12.14% | 13.71% | 16.64% | 11.78% | 15.18% | 20.47% | 24.52% | 23.30% | 22.05% | 19.43% | 19.59% | 15.65% |
| Income Tax Expense | 14.64M | 13.07M | 8.40M | 13.32M | 7.39M | 12.64M | 11.17M | 8.89M | 9.71M | 9.61M | 9.41M | 7.14M | 3.53M |
| Net Income | 85.44M | 102.46M | 104.65M | 102.90M | 66.98M | 66.17M | 65.81M | 64.60M | 58.77M | 54.22M | 44.47M | 34.06M | 19.79M |
| Net Income Ratio | 8.37% | 10.12% | 12.21% | 14.42% | 10.78% | 13.05% | 17.52% | 21.44% | 19.99% | 18.71% | 16.03% | 16.20% | 13.28% |
| EPS | 0.44 | 0.53 | 0.64 | 0.67 | 0.44 | 0.44 | 0.43 | 0.56 | 0.52 | 0.48 | 0.39 | 0.30 | 0.18 |
| EPS Diluted | 0.44 | 0.53 | 0.64 | 0.67 | 0.43 | 0.44 | 0.43 | 0.56 | 0.52 | 0.48 | 0.39 | 0.30 | 0.18 |
| Weighted Avg Shares Out | 194.19M | 193.53M | 163.51M | 153.59M | 152.22M | 150.38M | 151.33M | 115.36M | 113.34M | 113.03M | 113.57M | 113.59M | 110.02M |
| Weighted Avg Shares Out (Dil) | 194.19M | 193.53M | 163.51M | 153.59M | 155.76M | 150.38M | 151.87M | 115.36M | 113.34M | 113.03M | 113.57M | 113.59M | 110.02M |
Source: https://incomestatements.info
Category: Stock Reports